Here are four key takeaways:
1. The device is indicated for the treatment of anterior cervical interbody fusion procedures in adult patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc.
2. DIVERGENCE Stand Alone Interbody Cage is an all-in-one fusion device with internal screw fixation and incorporates divergent screw technique.
3. The device is designed for use in patients who have had six weeks of non-operative treatment.
4. A new Kalorama Information report named Medtronic as one of the biggest device companies in the market today. Medtronic leads the orthopedic spine device market and will likely continue as a leader there over the next few years, the report notes.
More articles on devices:
Zacks reaffirms Bacterin’s “hold rating”: 4 things to know
NuVasive launches alignment-focused spine system — 5 things to know
LinkSPINE receives FDA clearance for FacetLINK: 4 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
